small molecule

CRESTOR

ROSUVASTATIN CALCIUM

Loss of exclusivityloss of exclusivity
CompanyASTRAZENECA UK LTD

Drug detail

Brand nameCRESTOR
Active ingredientROSUVASTATIN CALCIUM
StrengthEQ 5MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2003
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CRESTOR patent cliff — loss of exclusivity — | CliffBio